Brokerages Set Pliant Therapeutics, Inc. (NASDAQ:PLRX) PT at $13.31
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have received an average rating of “Hold” from the twelve research firms that are currently covering the firm, Marketbeat Ratings reports. Twelve research analysts have rated the stock with a hold recommendation. The average twelve-month price target among brokerages that have covered the stock in […]
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have received an average rating of “Hold” from the twelve research firms that are currently covering the firm, Marketbeat Ratings reports. Twelve research analysts have rated the stock with a hold recommendation. The average twelve-month price target among brokerages that have covered the stock in […]
